4a3c00551560fc6303a85b6aa5a2d4c8
T-Cell Select™
OXFORD IMMUNOTEC LIMITED·III·Ecuador ARCSA·Registered June 09, 2023
Device classification
- Risk class
- III
- Product type
- In Vitro Diagnostic
- Commercial name
- 19-041 IVD Reagents/Testing Kits, Serology, Bacteria
Registration information
- Analysis ID
- 4a3c00551560fc6303a85b6aa5a2d4c8
- Registration date
- June 09, 2023
- Expiration date
- June 09, 2028
Manufacturer
- City
- ABINGDON
- Country
- UNITED KINGDOM OF GREAT BRITAIN
- Address
- 143 PARK DRIVE EAST, MILTON PARK, ABINGDON, OXFORDSHIRE, OX14 4SE, U.K
Product owner
- Name
- OXFORD IMMUNOTEC LIMITED
- Country
- UNITED KINGDOM OF GREAT BRITAIN
Authorized representative
- Address
- URB BELLAVISTA ALTA 3RD TRANSVERSAL N61-37 AND SABANILLA
- Phone
- 2293537
Product use
INTENDED FOR THE ISOLATION OF WHOLE BLOOD MONONUCLEAR IMMUNE CELLS
About this record
Access comprehensive regulatory information for T-Cell Select™ in the Ecuador medical device market through Pure Global AI's free database. This III medical device is registered under ARCSA ID 4a3c00551560fc6303a85b6aa5a2d4c8 and manufactured by OXFORD IMMUNOTEC LIMITED. The device was registered on June 09, 2023.
This page provides complete registration details including product type (In Vitro Diagnostic), manufacturer information, authorized representative details, and regulatory compliance data from the official Ecuador ARCSA medical device database. Pure Global AI offers free access to Ecuador's complete medical device registry.